PatientsVille.com Logo


Harnal Medical Research Studies

Up-to-date List of Harnal Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Harnal Medical Research Studies

Rank Status Study
1 Unknown  Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Tamsulosin 0.4mg;   Drug: Tamsulosin 0.2mg
Outcome Measures: Changes of the total International Prostate Symptom Score (IPSS) score from baseline to 12 weeks of treatment in patients with severe symptomatic BPH refractory to tamsulosin 0.2mg (Harnal® 0.2mg, 1T);   Changes of maximal flow rate and post-voided residual urine volume after 4 and 12 weeks treatment.;   Changes of parameters in voiding diary after 4 and 12 weeks treatment.
2 Recruiting A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy Subjects
Conditions: Healthy;   Pharmacokinetics of Tamsulosin Hydrochloride
Interventions: Drug: Tamsulosin formulation-A;   Drug: Tamsulosin formulation-B
Outcome Measures: Pharmacokinetic parameter of tamsulosin (AUC0-t);   Pharmacokinetic parameter of tamsulosin (Cmax);   Pharmacokinetic parameter of tamsulosin (AUC0-∞);   Pharmacokinetic parameter of tamsulosin (Tmax);   Pharmacokinetic parameter of tamsulosin (T1/2);   Safety evaluated by physical examinations, vital signs, electrocardiograms, laboratory assessments, and adverse events.
3 Recruiting A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia
Condition: Benign Prostate Hyperplasia
Interventions: Drug: ASP4901;   Drug: Tamsulosin;   Drug: Placebo
Outcome Measures: Change from baseline in total IPSS (International Prostate Symptom Score);   Change from baseline in each symptom score of IPSS;   Change from baseline in IPSS QOL (quality of life) score;   Proportion of IPSS responder;   Plasma concentration of ASP4901;   Safety assessed by the incidence of adverse events, vital signs, labo-tests and 12-lead ECGs
4 Not yet recruiting The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia
Conditions: Chronic Kidney Failure;   Prostatic Hyperplasia
Intervention: Drug: Tamsulosin
Outcome Measures: Maximal flow rate;   Maximal detrusor pressure;   Bladder outlet obstruction index;   schäfer grade;   Compliance;   Estimated glomerular filtration rate;   Urinary protein to creatinine ratio

These studies may lead to new treatments and are adding insight into Harnal etiology and treatment.

A major focus of Harnal research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.

Discuss Harnal